INCYIncyte
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Oversold (RSI 19). Price is +7% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How INCY is trading
Incyte is +31% over the past year while the S&P 500 is +18%: 13 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +6.6%
vs 200-day average · close to trend
- RSI (14)
- 19
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 13%
Below its 52-week high
Details›
- Last close2026-10-09
- $112.81
- 1 monthS&P 500 +2.7%
- −8.5%
- 1 yearS&P 500 +18%
- +31%
- 5 yearsS&P 500 +88%
- +56%
- vs 50-day average$122.66
- −8.0%
- 52-week high
- $129.88
- 52-week low
- $81.66
- Annualised volatility
- 35%
| Year | Return |
|---|---|
| 2026 (year to date) | +14% |
| 2025 | +43% |
| 2024 | +10% |
| 2023 | −22% |
| 2022 | +9.4% |
| 2021 | −16% |
| 2020 | −0.39% |
| 2019 | +37% |
| 2018 | −33% |
| 2017 | −5.5% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +3.9% |
| Feb | 10 | 4 of 10 | −1.6% |
| Mar | 10 | 3 of 10 | −1.8% |
| Apr | 10 | 5 of 10 | −1.2% |
| May | 10 | 8 of 10 | +2.0% |
| Jun | 10 | 8 of 10 | +2.9% |
| Jul | 11 | 7 of 11 | +4.2% |
| Aug | 11 | 5 of 11 | −0.22% |
| Sep | 11 | 3 of 11 | −4.4% |
| Oct | 11 | 4 of 11 | +0.94% |
| Nov | 10 | 7 of 10 | +3.5% |
| Dec | 10 | 4 of 10 | +0.02% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry